BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17227797)

  • 1. Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay.
    Schneiderhan W; Diaz F; Fundel M; Zhou S; Siech M; Hasel C; Möller P; Gschwend JE; Seufferlein T; Gress T; Adler G; Bachem MG
    J Cell Sci; 2007 Feb; 120(Pt 3):512-9. PubMed ID: 17227797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
    Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
    Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo matrix metalloproteinase production by pancreatic cancer cells and by distant organs.
    Haq M; Shaeii AE; Zervos EE; Rosemurgy AS
    Int J Surg Investig; 2000; 1(6):459-65. PubMed ID: 11729853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
    Zervos EE; Shafii AE; Rosemurgy AS
    J Surg Res; 1999 Jan; 81(1):65-8. PubMed ID: 9889060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
    Ikenaga N; Ohuchida K; Mizumoto K; Cui L; Kayashima T; Morimatsu K; Moriyama T; Nakata K; Fujita H; Tanaka M
    Gastroenterology; 2010 Sep; 139(3):1041-51, 1051.e1-8. PubMed ID: 20685603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
    Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
    Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fibrillar Tenascin-C in metastatic pancreatic cancer.
    Chen J; Chen Z; Chen M; Li D; Li Z; Xiong Y; Dong J; Li X
    Int J Oncol; 2009 Apr; 34(4):1029-36. PubMed ID: 19287959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic stellate cells: partners in crime with pancreatic cancer cells.
    Vonlaufen A; Joshi S; Qu C; Phillips PA; Xu Z; Parker NR; Toi CS; Pirola RC; Wilson JS; Goldstein D; Apte MV
    Cancer Res; 2008 Apr; 68(7):2085-93. PubMed ID: 18381413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro.
    Zervos EE; Shafii AE; Haq M; Rosemurgy AS
    J Surg Res; 1999 Jun; 84(2):162-7. PubMed ID: 10357914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
    Fujisawa T; Joshi B; Nakajima A; Puri RK
    Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells.
    Kuwada Y; Sasaki T; Morinaka K; Kitadai Y; Mukaida N; Chayama K
    Int J Oncol; 2003 Apr; 22(4):765-71. PubMed ID: 12632066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo.
    Bloomston M; Shafii A; Zervos E; Rosemurgy AS
    Am J Surg; 2005 Jun; 189(6):675-9. PubMed ID: 15910719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
    Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
    Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo.
    Nilsson UW; Dabrosin C
    Cancer Res; 2006 May; 66(9):4789-94. PubMed ID: 16651433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147.
    Li M; Zhai Q; Bharadwaj U; Wang H; Li F; Fisher WE; Chen C; Yao Q
    Cancer; 2006 May; 106(10):2284-94. PubMed ID: 16604531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma.
    Cao Z; Xiang J; Li C
    Int J Oral Maxillofac Surg; 2009 Aug; 38(8):880-5. PubMed ID: 19372030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Arch Dermatol Res; 2005 Oct; 297(4):154-60. PubMed ID: 16047212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived pancreatic stellate cells promote pancreatic cancer cell invasion through release of thrombospondin-2.
    Farrow B; Berger DH; Rowley D
    J Surg Res; 2009 Sep; 156(1):155-60. PubMed ID: 19592030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer.
    Bloomston M; Shafii A; Zervos EE; Rojiani A; Rosemurgy AS
    J Surg Res; 2002 Jan; 102(1):35-8. PubMed ID: 11792149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of RNAi-mediated STAT3 gene inhibition on metastasis of human pancreatic cancer cells].
    Gao Z; Huang C; Qiu ZJ; Jiang T; Zhu L; Cao J; Zhang F; Huang KJ
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):1010-3. PubMed ID: 19035205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.